Dongwha Pharm.Co.,Ltd Statistics
Total Valuation
KRX:000020 has a market cap or net worth of KRW 171.30 billion. The enterprise value is 254.25 billion.
Market Cap | 171.30B |
Enterprise Value | 254.25B |
Important Dates
The last earnings date was Monday, March 24, 2025.
Earnings Date | Mar 24, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:000020 has 27.72 million shares outstanding. The number of shares has increased by 0.12% in one year.
Current Share Class | n/a |
Shares Outstanding | 27.72M |
Shares Change (YoY) | +0.12% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 11.34% |
Owned by Institutions (%) | 9.06% |
Float | 18.97M |
Valuation Ratios
The trailing PE ratio is 30.79.
PE Ratio | 30.79 |
Forward PE | n/a |
PS Ratio | 0.37 |
PB Ratio | 0.43 |
P/TBV Ratio | 0.59 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.74, with an EV/FCF ratio of -6.25.
EV / Earnings | 45.70 |
EV / Sales | 0.55 |
EV / EBITDA | 7.74 |
EV / EBIT | 19.27 |
EV / FCF | -6.25 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.24.
Current Ratio | 1.79 |
Quick Ratio | 1.08 |
Debt / Equity | 0.24 |
Debt / EBITDA | 2.93 |
Debt / FCF | -2.38 |
Interest Coverage | 6.23 |
Financial Efficiency
Return on equity (ROE) is 0.53% and return on invested capital (ROIC) is 1.76%.
Return on Equity (ROE) | 0.53% |
Return on Assets (ROA) | 1.42% |
Return on Invested Capital (ROIC) | 1.76% |
Return on Capital Employed (ROCE) | 2.76% |
Revenue Per Employee | 569.70M |
Profits Per Employee | 6.82M |
Employee Count | 816 |
Asset Turnover | 0.79 |
Inventory Turnover | 3.13 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.91% in the last 52 weeks. The beta is 1.23, so KRX:000020's price volatility has been higher than the market average.
Beta (5Y) | 1.23 |
52-Week Price Change | -26.91% |
50-Day Moving Average | 6,121.00 |
200-Day Moving Average | 7,051.15 |
Relative Strength Index (RSI) | 57.57 |
Average Volume (20 Days) | 36,217 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:000020 had revenue of KRW 464.87 billion and earned 5.56 billion in profits. Earnings per share was 200.71.
Revenue | 464.87B |
Gross Profit | 214.26B |
Operating Income | 13.41B |
Pretax Income | 6.90B |
Net Income | 5.56B |
EBITDA | 33.08B |
EBIT | 13.41B |
Earnings Per Share (EPS) | 200.71 |
Balance Sheet
The company has 43.50 billion in cash and 96.99 billion in debt, giving a net cash position of -53.49 billion or -1,929.88 per share.
Cash & Cash Equivalents | 43.50B |
Total Debt | 96.99B |
Net Cash | -53.49B |
Net Cash Per Share | -1,929.88 |
Equity (Book Value) | 402.83B |
Book Value Per Share | 13,470.37 |
Working Capital | 104.95B |
Cash Flow
In the last 12 months, operating cash flow was -4.00 billion and capital expenditures -36.69 billion, giving a free cash flow of -40.69 billion.
Operating Cash Flow | -4.00B |
Capital Expenditures | -36.69B |
Free Cash Flow | -40.69B |
FCF Per Share | -1,467.95 |
Margins
Gross margin is 46.09%, with operating and profit margins of 2.88% and 1.20%.
Gross Margin | 46.09% |
Operating Margin | 2.88% |
Pretax Margin | 1.48% |
Profit Margin | 1.20% |
EBITDA Margin | 7.12% |
EBIT Margin | 2.88% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 180.00, which amounts to a dividend yield of 2.95%.
Dividend Per Share | 180.00 |
Dividend Yield | 2.95% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 89.68% |
Buyback Yield | -0.12% |
Shareholder Yield | 2.83% |
Earnings Yield | 3.25% |
FCF Yield | -23.75% |
Stock Splits
The last stock split was on June 30, 2009. It was a forward split with a ratio of 5.
Last Split Date | Jun 30, 2009 |
Split Type | Forward |
Split Ratio | 5 |
Scores
KRX:000020 has an Altman Z-Score of 2.33. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.33 |
Piotroski F-Score | n/a |